"Galectins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of animal lectins that bind specifically to beta-galactoside in a calcium-independent manner. Members of this class are distiguished from other lectins by the presence of a conserved carbohydrate recognition domain. The majority of proteins in this class bind to sugar molecules in a sulfhydryl-dependent manner and are often referred to as S-type lectins, however this property is not required for membership in this class.
| Descriptor ID |
D037161
|
| MeSH Number(s) |
D12.776.503.307
|
| Concept/Terms |
Galectins- Galectins
- beta-Galactoside Binding Lectin
- Binding Lectin, beta-Galactoside
- Lectin, beta-Galactoside Binding
- beta Galactoside Binding Lectin
- D-Galactoside-Binding Lectin
- D Galactoside Binding Lectin
- Lectin, D-Galactoside-Binding
- S-Type Lectins
- S Type Lectins
- Galaptins
- Galectin
- Lectins, S-Type
- Lectins, S Type
- S-Type Lectin
- Lectin, S-Type
- S Type Lectin
- beta-D-Galactosyl-Specific Lectin
- Lectin, beta-D-Galactosyl-Specific
- beta D Galactosyl Specific Lectin
- Galactose-Binding Lectin
- Galactose Binding Lectin
- Lectin, Galactose-Binding
|
Below are MeSH descriptors whose meaning is more general than "Galectins".
Below are MeSH descriptors whose meaning is more specific than "Galectins".
This graph shows the total number of publications written about "Galectins" by people in this website by year, and whether "Galectins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 2 | 3 | 5 |
| 2021 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Galectins" by people in Profiles.
-
Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes. ASAIO J. 2025 Feb 01; 71(2):136-142.
-
Physical tuning of galectin-3 signaling. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
-
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial. J Am Heart Assoc. 2020 01 07; 9(1):e012797.
-
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. Gastroenterology. 2020 04; 158(5):1334-1345.e5.
-
Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery. Am Heart J. 2020 02; 220:253-263.
-
Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery. Ann Thorac Surg. 2020 01; 109(1):164-170.
-
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy. J Immunother Cancer. 2019 07 10; 7(1):175.
-
Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma. Biomark Med. 2019 06; 13(9):715-724.
-
Engineering galectin-glycan interactions for immunotherapy and immunomodulation. Exp Biol Med (Maywood). 2016 05; 241(10):1074-83.
-
A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology. Appl Immunohistochem Mol Morphol. 2015 Aug; 23(7):481-90.